The expression of molecular markers for estrogen receptors (ER) or progesterone receptors (PR) and human epidermal growth factor 2 (HER2) are used as classification factors and play an essential role in the treatment of patients with invasive breast cancer (Duffy et al. 2017). The gene discussed is ESR1; the disease is invasive breast carcinoma.